CONMED Balance Sheet
NYSE: CNMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CONMED financial position
At the end of fiscal 2025, CONMED reported total assets of $2.33 billion, up 0.8% from a year earlier against total liabilities of $1.29 billion. Shareholders' equity stood at $1.03 billion, or 44.4% of assets. The company held $40.8 million in cash and equivalents against $834.9 million of debt, a net debt position of $794.1 million.
The current ratio (current assets divided by current liabilities) was 2.14, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.81.
Summary generated from market data by MetaCap's automated system. Methodology
CONMED balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 40.82M | 24.46M | 24.30M | 28.94M | 20.85M | 27.36M | 25.86M | 17.51M | 32.62M | 27.43M |
| Receivables | 247.83M | 237.73M | 242.28M | 191.34M | 183.88M | 177.15M | 189.10M | 181.55M | 167.04M | 148.24M |
| Inventory | 355.54M | 346.72M | 318.32M | 332.32M | 231.64M | 194.87M | 164.62M | 154.60M | 141.44M | 135.87M |
| Total Current Assets | 672.86M | 640.01M | 615.65M | 581.23M | 460.12M | 416.65M | 397.36M | 374.35M | 356.78M | 330.51M |
| Property, Plant & Equipment | 113.33M | 115.79M | 120.72M | 115.61M | 108.86M | 111.41M | 118.88M | 113.25M | 116.23M | 122.03M |
| Goodwill | 807.01M | 805.36M | 806.84M | 815.43M | 617.53M | 618.44M | 618.04M | 400.44M | 401.95M | 397.66M |
| Intangible Assets | 582.05M | 617.66M | 649.48M | 681.80M | 471.05M | 501.54M | 532.80M | 413.19M | 414.94M | 419.55M |
| Total Assets | 2.33B | 2.31B | 2.30B | 2.30B | 1.77B | 1.75B | 1.78B | 1.37B | 1.36B | 1.33B |
| Accounts Payable | 93.65M | 102.25M | 88.22M | 73.39M | 58.20M | 53.31M | 55.97M | 53.50M | 42.04M | 41.65M |
| Short-Term Debt | 712.00K | 715.00K | 708.00K | 69.75M | 12.25M | 18.41M | 13.60M | 18.34M | 14.70M | 10.20M |
| Total Current Liabilities | 315.04M | 278.13M | 310.73M | 296.55M | 196.65M | 190.20M | 188.09M | 160.94M | 150.00M | 113.95M |
| Long-Term Debt | 834.23M | 905.07M | 973.14M | 985.08M | 672.41M | 735.22M | 755.21M | 438.56M | 471.74M | 488.29M |
| Total Liabilities | 1.29B | 1.34B | 1.47B | 1.55B | 980.58M | 1.04B | 1.06B | 706.87M | 726.53M | 748.41M |
| Shareholders' Equity | 1.03B | 962.68M | 834.22M | 745.54M | 785.43M | 709.04M | 710.47M | 662.27M | 631.43M | 580.58M |
| Retained Earnings | 588.77M | 560.28M | 452.53M | 412.63M | 496.61M | 457.42M | 470.84M | 464.85M | 440.08M | 406.93M |
| Total Debt | 834.94M | 905.78M | 973.85M | 1.05B | 684.66M | 753.64M | 768.81M | 456.90M | 486.44M | 498.49M |
| Net Cash (Debt) | -794.13M | -881.32M | -949.55M | -1.03B | -663.81M | -726.28M | -742.95M | -439.39M | -453.82M | -471.06M |
This table shows 10 annual periods of CONMED's balance sheet, from FY 2025 back to FY 2016, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow CNMD's reporting calendar. What is a balance sheet?